Anavex Life Sciences (AVXL) Cash from Operations (2010 - 2026)
Anavex Life Sciences (AVXL) reported Cash from Operations of -$9.1 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$12.46 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Cash from Operations (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Anavex Life Sciences' Cash from Operations came in at -$29.29 million; for FY2025 (ended Sep 30, 2025), it was -$39.04 million.
- By fiscal year, Cash from Operations came in at -$30.81 million in FY2024, -$27.79 million in FY2023, -$24.24 million in FY2022 and -$30.38 million in FY2021.
- Five-year quarterly Cash from Operations spans a low of -$12.46 million in fiscal Q3 2025 and a high of -$3.5 million in fiscal Q1 2022.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$4.44 million (Q2 2026), -$7.15 million (Q1 2026) and -$8.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | -9.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.10 Mn |
| Mar 31, 2026 | -4.44 Mn |
| Dec 31, 2025 | -7.15 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -12.46 Mn |
| Mar 31, 2025 | -5.86 Mn |
| Dec 31, 2024 | -12.12 Mn |
| Sep 30, 2024 | -6.66 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Mar 31, 2024 | -11.66 Mn |
| Dec 31, 2023 | -7.32 Mn |
| Sep 30, 2023 | -5.85 Mn |
| Jun 30, 2023 | -7.65 Mn |
| Mar 31, 2023 | -8.49 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -4.04 Mn |
| Jun 30, 2022 | -7.05 Mn |
| Mar 31, 2022 | -9.64 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Sep 30, 2021 | -7.67 Mn |
API Access
Anavex Life Sciences Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();